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Abstract
Background The concept of osseointegration involves
direct contact between titanium implant and bone. This
transcutaneous prosthetic system for amputees is intended
to assure stable long-term ﬁxation. Most metal transcuta-
neous implants have failed, primarily owing to infection.
Questions/purposes We determined the frequency and
describe the presentation of infectious complications with
this novel method. We also evaluated the bacterial ﬂora at
the skin-penetration area and its relation to the develop-
ment of local and implant-related infection.
Patients and Methods We prospectively followed 39
patients with arm and leg amputations ﬁtted with transcu-
taneous osseointegrated titanium implants a mean of
56 months earlier (range, 132–133 months). There were 33
femoral, one tibial, four ulnar, four radial, and three
humeral implants. Patients were selected during a 6-month
period in 2005 and identically reevaluated after 3 years.
Implant infection was deﬁned as deﬁnite, probable, or
possible based on clinical, radiologic, and microbiologic
evidence.
Results The frequency of implant infection was 5% at
inclusion and 18% at followup. One patient with infection
recovered owing to antibiotic treatment and another patient
had the implant removed. Most implant infections had low
infectious activity, and in ﬁve of the seven patients with
infections,prostheticusewasnotaffected.Themostcommon
bacteriainsuperﬁcialanddeepcultureswereStaphylococcus
aureus and coagulase-negative staphylococci.
Conclusions Despite frequent colonization around the
skin-implant interface by potentially virulent bacteria such
as Staphylococcus aureus and bacteria associated with
biomedical device infections such as coagulase-negative
staphylococci, this titanium implant system for bone-
anchored prostheses caused few infections leading to dis-
ability or implant removal.
Level of Evidence Level IV, therapeutic study. See the
Guidelines for Authors for a complete description of levels
of evidence.
Introduction
In high-income countries, chronic vascular disease is the
leading cause of limb loss [22]. However, many previously
healthy individuals undergoamputationsecondary totrauma,
neoplasia, infection, and arterial embolism [12]. The con-
ventionalwaytosuspendaprostheticlimbtothebodyiswitha
prosthetic socket [20]. Users of socket prostheses commonly
report impaired quality of life [8, 13, 26, 27] and complica-
tions including dermatitis and infected sores [10, 21].
Prosthetic bone anchorage is intended to eliminate or
minimize these problems. Our novel method is based on
the principles of osseointegration (Fig. 1), which has been
One or more of the authors (JT, LH) have received funding from the
LUA project (ALFGBG-11128), University of Gothenburg, Go ¨teborg,
Sweden.
Each author certiﬁes that his or her institution has approved the
human protocol for this investigation and that all investigations were
conducted in conformity with ethical principles of research, and that
informed consent for participation in the study was obtained.
J. Tillander (&), L. Hagberg
Department of Infectious Diseases, University of Gothenburg,
SE-416 85 Go ¨teborg, Sweden
e-mail: jonatan.tillander@vgregion.se
K. Hagberg, R. Bra ˚nemark
Department of Orthopedics, University of Gothenburg,
Go ¨teborg, Sweden
123
Clin Orthop Relat Res (2010) 468:2781–2788
DOI 10.1007/s11999-010-1370-0in clinical use in prosthetic teeth replacement since 1965
[4]. One report suggests a 15-year implant survival rate of
approximately 90% in mandibular bone [1]. With osseo-
integration, direct contact between ﬁxture and bone tissue
is intended, assuring a stable, long-term attachment for the
external prosthesis [5]. This technique results in easy
prosthesis handling, improved limb control, and eliminates
socket-impaired ROM and socket-caused skin disorders
[15, 16, 30] (Fig. 2). During the years, various attempts to
anchor prosthetic limbs with transcutaneous metal implants
other than titanium [17, 18, 25] have failed, primarily
owing to infection. Currently, our center has treated more
than 100 patients with femoral titanium implants (Fig. 3),
three with tibial implants, 15 with humeral implants, and
20 with ulnar and/or radial implants. Treatment failures
were more common before we introduced a standardized
treatment protocol in 1999 [14, 28].
Clinical observations have led us to believe that poor
primary osseointegration increases the risk of subsequent
infection. However, this is not substantiated. Experimental
evidence supports antiinfectious properties of titanium
compared with other biomaterials when implanted in bone
and in soft tissues [2, 7]. Medical device infection is caused
predominantly by staphylococci, with coagulase-negative
staphylococci being the most common [32, 33]. However,
as the deﬁnitive diagnosis of infection is sometimes a
problem, culture-based algorithms have been developed to
increase diagnostic sensitivity [3, 19, 23, 32, 33]. We
therefore base our deﬁnitions of infection on clinical,
radiographic, and bacteriologic ﬁndings. Although current
titanium transcutaneous implants are intended to reduce
infections compared with previously used metals and
transcutaneous techniques, there are little data regarding
infections with these implants. In the related but incom-
parable setting of dental osseointegration, infection is well
characterized [31], but less has been published regarding
infection in bone-anchored hearing aids [29].
Our aims were (1) to describe the frequency and (2) the
bacterial ﬂora at the skin-penetration area and its relation to
the development of local and implant-related infection in
this novel method. The various clinical presentations of
implant infections also are described.
Patients and Methods
We prospectively studied bacterial colonization and
infectious complications in 39 patients with arm and leg
amputations previously treated with 45 transcutaneous
osseointegrated titanium implants. All patients attending
Fig. 1 This schematic drawing shows the implant components and
surrounding tissues.
Fig. 2 This is a ventral view of the transcutaneous component
(abutment) in a patient with a transfemoral amputation. (Published
with permission from Nigel Jarvis, the University of Gothenburg, The
Sahlgrenska Academy, Gothenburg, Sweden.)
Fig. 3 A lateral view is shown of a patient securing an external
prosthesis to the abutment. (Published with permission from Nigel
Jarvis, the University of Gothenburg, The Sahlgrenska Academy,
Gothenburg, Sweden.)
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123the osseointegration outpatient clinic at Sahlgrenska Uni-
versity Hospital, Go ¨teborg, Sweden, for scheduled or
emergency visits between January and June 2005 were
included. No patients refused to participate. At least
3 months had elapsed since the second surgical procedure
(abutment insertion). This cohort was followed longitudi-
nally for an average of 3 years to identify implant
infections and cross sectionally surveyed twice (at inclu-
sion and after approximately 3 years) for bacterial
presence, local infection, and antibiotic use. All skin-
penetrating loci were subjected to separate clinical, bacte-
riologic, and radiographic assessment. There were 18
women and 21 men with a mean age of 49.3 years (range,
28–74 years). Amputations were the result of either trauma
or neoplasia. Thirty-three of the implants were femoral
(bilateral in one), four each were ulnar and radial (bilateral
in one), three were humeral, and one was tibial. The
patients had been living with the implant(s) a mean of
54 months (range, 3–132 months). Indications for these
implants were severe discomfort when using conventional
socket prostheses or poor stump conditions [13].
The treatment involves two separate surgical proce-
dures. A titanium screw (ﬁxture) is inserted into the
residual bone and allowed to integrate for 6 months before
the skin-penetrating extension (abutment) is inserted [28].
Based on the experience of successful skin-penetrating
implants in the head and neck regions [29], the skin is
attached directly to the distal end of the residual bone to
reduce soft tissue mobility and risk of infection. We con-
sider the implant osseointegrated when it is stable on
clinical examination, pain free when loaded [28], and there
are no signs of loosening seen on radiographs, ie, no
radiolucent zone around the implant. Postoperative fol-
lowup includes clinical examination (pain evaluation,
implant stability, skin and soft tissue condition), a reha-
bilitation protocol [14], and radiographs at 6 months and 1,
2, 3, 5, 7, 10, and 15 years after surgery.
We used the following ﬁve deﬁnitions for implant
infection and required all stated criteria for the given
diagnosis: (1) deﬁnite implant infection: (a) clinical
symptoms of implant-related infection, (b) radiographic
signs consistent with periimplant bone infection, and (c) at
least three of ﬁve intraoperatively obtained cultures
yielding identical pathogens; (2) probable implant infec-
tion: (a) clinical symptoms of implant-related infection, (b)
radiographic signs consistent with periimplant bone infec-
tion, and (c) positive relevant culture not as deﬁned
previously; (3) possible implant infection: (a) clinical
symptoms of implant-related infection, (b) radiographic
signs consistent with periimplant bone infection, and (c) no
relevant cultures; (4) local infection in the skin penetration
area: (a) local signs/symptoms of infection (inﬂammation
with or without secretion) in the skin penetration area but
no symptoms of deep infection, (b) no radiographic signs
consistent with periimplant bone infection, and (c) with or
without relevant cultures; (5) bacterial colonization around
the skin-implant interface: (a) neither local inﬂammatory
signs nor other clinical symptoms of infection, with or
without secretion, at the skin-implant interface, (b) no
radiographic signs consistent with periimplant bone infec-
tion, and (c) positive bacterial culture from the skin-
implant interface. We considered radiographic evidence of
osteolysis with or without periosteal sclerosis around a
previously integrated implant to be consistent with implant
infection. The deﬁnitions also were based on previously
proposed culture diagnostics in infected hip and knee
arthroplasties [19, 23].
At inclusion patients were examined clinically and
asked to answer a questionnaire (Appendix 1) regarding
infectious complications and antibiotic use during the
6 months preceding the visit. Without any preparation of
the surrounding skin, samples were taken from the skin-
implant interface with a sterile cotton swab, transported in
a coal-based medium, and cultured on routine agar plates
for at least 2 days. A second set of bacterial cultures was
performed 3 years later and an identical questionnaire was
answered. Patients who were not scheduled for a visit at
this time collected bacterial samples (cotton swabs)
themselves according to careful written instructions and, if
necessary, with the assistance of their attending clinic.
These patients were experienced in handling the skin-
implant area and we anticipated no methodologic problems
with the patients performing their own cultures. Cultures
and questionnaires were sent to Sahlgrenska University
Hospital by mail. Sampled cultures transported in a coal-
based medium are expected to survive a 2-day transport by
mail. Culturing the samples then was performed at our
certiﬁed laboratory.
All cultures were examined by one (SK) experienced
bacteriologic analyst. The number of colony forming units
(CFU) was deﬁned as +++ ([100 CFU), ++ (10–
100 CFU), or + (\10 CFU). A routine disk method was
used to determine antibiotic resistance.
The latest scheduled or symptom-prompted radiographs
at inclusion and followup were checked for signs of bone
infection. All patients had radiographs performed within
6 months of inclusion. Followup radiographs were
obtained for 31 patients. Of the remaining eight patients,
two already had osteomyelitic changes at the beginning of
the study, four were excluded, and two were without
infectious symptoms.
Four patients were lost to followup. In one, the implant
was extracted owing to mechanical loosening in a previ-
ously radiated femur (October 2006). In another patient,
chronic skin infection led to abutment removal (February
2007). Complete skin healing over the retained implant
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followup protocol for nonmedical reasons. Their admitting
medical centers were contacted and no implant infections
were reported. The study was approved by the ethical
committee at the University of Gothenburg.
Results
The frequencies for patients with deﬁnite/probable/possible
implant infections were 5% (two of 39) at inclusion and
18% (seven of 39) at followup (Table 1). Seven patients
had a history of local infection at the skin penetration area
during the 6-month period before inclusion and 11 patients
had local infections during the 6-month period before fol-
lowup (Table 1). Four and six patients, respectively, had
been treated with short-term oral antibiotics. Fourteen
patients had secretion from the skin pocket. In 10 patients,
the secretion was purulent.
The most common bacteria found around the skin-
implant interface were Staphylococcus aureus, coagulase-
negative staphylococci, and streptococci group A, B, or G.
In three of seven patients with implant infections at fol-
lowup, inclusion cultures from the skin-implant interface
yielded the same species as the suspected infectious agent
(Table 2). Staphylococcus aureus was cultured from
Table 1. Bacterial colonization and infection at the beginning of the study and at followup
Type of infection Initial assessment Followup (2-3 years)
Possible/probable/deﬁnite implant infection 2 6

Local soft tissue infection in the skin penetration area* 7 11
Superﬁcial colonization without signs of infection 23 (24)
 16 (17)
No growth of bacteria or signs of infection 7 (12) 2 (4)
Lost for followup
§ 4
* Including all episodes of infection during 6 months before ﬁrst and second assessments;
ﬁgures in parentheses correspond to total number of
clinical sites, which exceed the number of patients; three patients had more than one implant;
total number of implant infections during the
3-year study was seven; one patient had been treated successfully at followup;
§contact with admitting clinic indicated no implant infection.
Table 2. Bacterial ﬁndings at the skin-implant interface at ﬁrst observation and second observations 2.5 to 3 years later*
Bacteria First observation (n = 39) Second observation (n = 30) Not
quantiﬁed
Number
of patients
§
+++ Bacterial colonies Number
of patients
§
+++ Bacterial colonies
++ + ++ +
S. aureus 16
 93 4 1 9 1 1 0 1 7
CoNS 10 0 5 5 11 4 1 4 2
Streptococcus group B 6 2 1 3 3 3 0 0 0
Streptococcus group G 2 1 0 1 0 — — — —
Streptococcus group A 1 1 0 0 0 — — — —
Enterococci 3 2 1 0 1 — — — 1
Citrobacter sp. 2 1 0 1 0 — — — —
Proteus mirabilis 1 1 0 0 0 — — — —
Serratia sp. 1 1 0 0 2 2 0 0 0
P. aeruginosa 2 1 0 1 1 1 — — 0
Other Gram-negative rods 1 0 0 1 2 1 1 — 0
Aerobic streptococci nontypable 1 0 0 1 0 — — — —
Alfa streptococci 1 0 1 0 1 — — — 1
Coryneforms 0 0 0 0 1 1 0 0 0
No growth 8 0
Excluded/no culture 9
* Several patients had more than one bacterial species isolated;
one patient had a positive S. aureus culture from two loci; CoNS = coagulase-
negative staphylococci;
§several patients had growth of two or more bacteria at the same site.
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123specimens from 16 patients (17 implants), coagulase-neg-
ative staphylococci from 10, streptococcus group B, G, or
nontypable from nine, beta-hemolytic streptococcus group
A from one, Enterococcus sp. from three, alfa streptococci
from one, and Gram-negative rods from four (Table 2)a t
inclusion. No Staphylococcus aureus strain was methicil-
lin-resistant.
Followup culture specimens were obtained from 30
patients,asﬁvepatientsdidnotsendspecimensasinstructed.
Staphylococcus aureus was still the most common ﬁnding
(19) followed by coagulase-negative staphylococci (11),
streptococcus group B (3), Serratia sp. (2) Enterococcus sp.,
alfa streptococcus, coryneforms, and Pseudomonas aeru-
ginosa (one each) (Table 2). No Staphylococcus aureus
strain was methicillin-resistant. Eight of 13 patients with
recultured specimens with Staphylococcus aureus at inclu-
sion also had Staphylococcus aureus isolated at followup.
The clinical presentation varied. Two patients had
chronic skin ﬁstulas to the implant with occasional secre-
tion but without pain, fever, or implant loosening. Fistulas
were present more than 5 years before inclusion and were
not treated with antibiotics during the observation time.
They were registered as implant infections at inclusion and
at followup. Staphylococcus aureus and coagulase-negative
staphylococci were suspected etiologic agents. Two
patients had implant infections with poor primary osseo-
integration. One had an infected femoral implant extracted.
Preoperative cultures showed coagulase-negative staphy-
lococci, alfa streptococci, and Peptostreptococcus sp. The
other patient had a humeral implant infection caused by
Escherichia coli. It was veriﬁed by biopsies of the culture
specimens and treated with ciproﬂoxacin for 6 months.
One year later, there were no signs of relapse. Distal
infection involving bone and soft tissue was seen in two
patients with good primary osseointegration. The etiology
was mixed with Staphylococcus aureus/coagulase-negative
staphylococci and Staphylococcus aureus/Enterococcus
faecalis being suspected. Both patients underwent surgical
revision and prolonged antibiotic treatment. Acute osteo-
myelitis occurred in one patient who had no fever but had
acute pain develop in an osseointegrated femur. Radiog-
raphy revealed signs of osteomyelitis at the midﬁxture
level. Intraoperative cultures yielded Staphylococcus aur-
eus and coagulase-negative staphylococci (Table 3). In two
of seven patients with implant infections at followup,
prosthetic use was not affected at any time, three patients
were affected only brieﬂy during the time around surgical
intervention, and for the patient with acute osteomyelitis,
the treatment outcome is still pending.
Discussion
Transcutaneous osseointegrated titanium implants for
prosthetic systems in patients with amputations provide
improved performance and less socket-caused complica-
tions in selected patients [15, 16]. Our aim was to describe
the frequency, clinical presentation, and bacterial occur-
rence in local and implant-related infections.
We acknowledge several limitations. First is the rela-
tively short followup, although some patients had been
living with the implant for more than 10 years. Most
patients were young or middle-aged and probably will
require use of their implants or other prostheses for
numerous decades. We cannot predict the long-term
durability of these implants. Second, we included some
Table 3. Etiology and outcome of patients with implant infections at followup
Age of
patient
(years)
Months since
surgical session
2 at inclusion
Months to
infection after
surgical session 2
Locus Suspected
bacterial
etiology*
Culture at skin
penetration area

Treatment given
at followup
Outcome
36 3 35 Femur S. aureus, CoNS No growth De ´bridement/clindamycin
+ rifampicin
Ongoing
40 24 36 Humerus E. coli CoNS Completed 6 months
ciproﬂoxacin
Recovered
45 84 31 Femur S. aureus,
E. faecalis
S. aureus, GBS Revision/teicoplanin Ongoing
49 18 36 Femur CoNS CoNS Clindamycin/extraction Implant
extraction
54 24 32 Femur S. aureus, GBS CoNS Flucloxacillin/revision/
clindamycin
Ongoing
65 96 60 Femur GBS GBS, P. mirabilis No treatment Ongoing, ﬁstulas
77 120 11 Femur CoNS S. aureus No treatment Ongoing, ﬁstulas
* Cultures taken from tissue specimens or from ﬁstulas;
bacterial swab taken at initial assessment from the area where the implant system
penetrates the skin; CoNS = coagulase-negative staphylococci; GBS = group B streptococci.
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123patients initially treated during a learning phase. The
enrolled patients represent all phases of method develop-
ment. We presume with experience the infection rates will
diminish. Third, we did not review all patients. Rather, we
studied a subgroup of 39 patients recruited during a
6-month period. As all patients attending (regular and
emergency visits) the clinic during the inclusion period
agreed to participate, we presume this cohort represents the
entire population. A retrospective analysis of implant
infection and risk factors in 100 patients treated with
femoral osseointegrated implants and a prospective analy-
sis of patients treated with the reﬁned protocol are in
progress.
Skin-penetrating implants were long regarded as unat-
tainable owing to the high rates of failure caused by
infection. The transcutaneous osseointegrated titanium
implant challenges this claim. In our cohort, seven of 39
(18%) patients either had an implant infection or one
developed within 3 years. The implant-infection/implant-
year ratio (7/135) is slightly less (5%) than comparable
results from Queen Mary’s Hospital in London where four
of 16 patients treated with the same method had an
implant-related infection develop during a cumulative 67-
year period (6%) (unpublished data, Sooriakumaran S,
Robinson KP, Ward DA, D0Arcy R, Chittoor SN, Written
communication from 12th ISPO Congress in Vancouver,
Canada, July 29, 2007). In our cohort, hematogenous and
ascending bacterial spread must be suspected. Poor pri-
mary osseointegration may have facilitated an ascending
infection as seen in two patients. Only one of seven
patients was diagnosed and treated for an implant-related
infection earlier than 31 months (mean, 34 months) after
the surgical procedure. With arthroplasty, late infection
([24 months) is considered more indicative of hematog-
enous seeding compared with early (\3 months) or
delayed (3–24 months) infections [33]. In our four cases
with more virulent bacteria, late onset of symptoms clearly
indicates that intraoperative contamination was not the
cause of infection. However, we cannot know whether
some of the infections were either of hematogenous or
new origin, rather than as a result of residual surgical
contamination.
We assessed the presence of local skin infections twice,
with a greater frequency at followup (Table 2). All epi-
sodes resolved spontaneously or with oral antibiotics
indicating no deeper infectious involvement. These adverse
effects must be compared with those of conventional
socket prostheses. For patients using conventional pros-
theses, socket-related problems such as ulcers and rashes
on the residual limb and restricted movement have been
described [8, 13]. In two studies, dermatologic problems
were reported to occur among 34% to 41% of those using
socket prostheses [10, 21]. Many of these are manageable.
With a bone-anchored prostheses however, no socket is
needed to suspend the artiﬁcial limb and consequently no
patient in our study had ulcers or contact dermatitis on the
residual limb.
Although various microorganisms may cause foreign
body-related infection, staphylococci are the most fre-
quently isolated pathogens [11, 32]. In our study,
approximately 1
.
2 of the patients were colonized with
potentially virulent Staphylococcus aureus in the skin
penetration area. Despite this, only three patients had a
Staphylococcus aureus implant infection. Unfortunately,
we did not perform genetic typing of the bacteria. The
ability to adhere to the implant material and to promote
bioﬁlm formation are important pathogenic properties for
staphylococci and other bacteria [9]. The biocompatibility
is greater with titanium [oxide] compared with stainless
steel and cobalt-chrome alloys [2, 7]. In osseointegration,
the tight junction formed between the titanium and the
bone tissue might prevent adhesion, colonization, and
subsequent bioﬁlm formation. Osseointegration also can be
established and maintained in aggressive inﬂammatory
environments such as experimental arthritis in a rabbit knee
model [6] and in patients with rheumatoid arthritis [24].
The osseointegration might explain why some patients with
implant infections have such slow, or even no, progressive
destruction of the bone tissue with subsequent loosening. It
also may explain why patients with poor primary osseo-
integration are more susceptible to infectious
complications.
We found the osseointegration method with titanium
implants and skin penetration of the titanium system in
patients with leg and arm amputations caused few severe
infectious complications. However, infectious complica-
tions occur in approximately two-ﬁfths of the patients
during a 3-year period, mostly as local infections in the
skin penetration area and more rarely as low-activity
implant-associated infections. Staphylococcus aureus and
coagulase-negative staphylococci were the most commonly
cultured bacteria in the skin penetration area. In our
opinion, the frequency and severity of infections do not
appear to be obstacles for use of this method. However,
future studies with longer followup will address risk factors
and speciﬁc infectious complications in an attempt to
reduce morbidity and increase usefulness of this novel
treatment.
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2008-08-20
Centre of Orthopaedic Osseointegration 
Sahlgrenska University Hospital, Gothenburg 
Dear……….,
A few years ago you participated in a study where a bacterial sample was taken from your 
skin penetration area. We found that many had growth of a number of different bacteria, 
which is to be expected considering bacteria are present on most surfaces of the body. We 
would now like a second sample to see if the same types of bacteria are present or if they are 
replaced by others. In addition to this we will study if certain bacteria are more prone to cause 
infection related to this type of prosthetic system. 
Therefore we would like you to open the enclosed plastic container and extract the cotton 
swab. Carefully sample the skin around the base of the abutment with the cotton tip. Make 
sure nothing else come in contact with the swab. Remove the lid of the transport tube and 
insert the swab all the way. Write the time when the sample was taken on the enclosed referral 
form and put both in the pre-franked envelope.
Please answer the questions of antibiotic usage and infections related to your osseointegrated 
prosthesis.
1. During the last six months, have you had any infectious complications in the skin or 
around the implant? If so, please describe. 
…………………………………………………………………………………………………
2. Has any antibiotic treatment been required during the last six months? 
…………………………………………………………………………………………………
3. If you answered yes on the previous question, please state which antibiotic agent, 
which dose and how long the treatment was.   
…………………………………………………………………………………………………
When answered, put this paper along with the sample and send it by mail the same day! 
Thank you very much for your help! Your participation means that we can develop and 
improve this method. 
Should you find these instructions difficult to carry out, seek assistance at your primary health 
provider or from your district nurse. If you have any questions please contact…….. at
+46 31…………or……………… at +46 31……………. 
Kind Regards Rickard Brånemark, Kerstin Hagberg, Lars Hagberg  
Volume 468, Number 10, October 2010 Infection in Osseointegrated Titanium Implants 2787
123References
1. Adell R, Eriksson B, Lekholm U, Bra ˚nemark PI, Jemt T. Long-
term follow-up study of osseointegrated implants in the treatment
of totally edentulous jaws. Int J Oral Maxillofac Implants.
1990;5:347–359.
2. Arens S, Schlegel U, Printzen G, Ziegler WJ, Perren SM, Hansis
M. Inﬂuence of materials for ﬁxation implants on local infection:
an experimental study of steel versus titanium DCP in rabbits.
J Bone Joint Surg Br. 1996;78:647–651.
3. Atkins BL, Athanasou N, Deeks JJ, Crook DW, Simpson H, Peto
TE, McLardy-Smith P, Berendt AR. Prospective evaluation of
criteria for microbiological diagnosis of prosthetic-joint infection
at revision arthroplasty: the OSIRIS Collaborative Study Group.
J Clin Microbiol. 1998;36:2932–2939.
4. Bra ˚nemark PI, Hansson BO, Adell R, Breine U, Lindstro ¨mJ ,
Halle ´n O, Ohman A. Osseointegrated implants in the treatment of
the edentulous jaw: experience from a 10-year period. Scand
J Plast Reconstr Surg Suppl. 1977;16:1–132.
5. Bra ˚nemark R, Bra ˚nemark PI, Rydevik B, Myers RR. Osseointe-
gration in skeletal reconstruction and rehabilitation: a review.
J Rehabil Res Dev. 2001;38:175–181.
6. Bra ˚nemark R, Thomsen P. Biomechanical and morphological
studies on osseointegration in immunological arthritis in rabbits.
Scand J Plast Reconstr Surg Hand Surg. 1997;31:185–195.
7. Cordero J, Munuera L, Folgueira MD. Inﬂuence of metal
implants on infection: an experimental study in rabbits. J Bone
Joint Surg Br. 1994;76:717–720.
8. Demet K, Martinet N, Guillemin F, Paysant J, Andre ´ JM. Health
related quality of life and related factors in 539 persons with
amputation of upper and lower limb. Disabil Rehabil.
2003;25:480–486.
9. Donlan RM, Costerton JW. Bioﬁlms: survival mechanisms of
clinically relevant microorganisms. Clin Microbiol Rev.
2002;15:167–193.
10. Dudek NL, Marks MB, Marshall SC, Chardon JP. Dermatologic
conditions associated with use of a lower-extremity prosthesis.
Arch Phys Med Rehabil. 2005;86:659–663.
11. Geipel U, Herrmann M. [The infected implant. Part 1: bacteriol-
ogy] [in German]. (Erratum in: Orthopade. 2005;34:119. Dosage
error in article text.) Orthopade. 2004;33:1411–1426; 1427–1428.
12. Global Lower Extremity Amputation Study Group. Epidemiology
of lower extremity amputation in centres in Europe, North
America and East Asia: the Global Lower Extremity Amputation
Study Group. Br J Surg. 2000;87:328–337.
13. Hagberg K, Bra ˚nemark R. Consequences of non-vascular trans-
femoral amputation: a survey of quality of life, prosthetic use and
problems. Prosthet Orthot Int. 2001;25:186–194.
14. Hagberg K, Bra ˚nemark R. One hundred patients treated with
osseointegrated transfemoral amputation prostheses: rehabilita-
tion perspective. J Rehabil Res Dev. 2009;46:331–344.
15. Hagberg K, Bra ˚nemark R, Gunterberg B, Rydevik B. Osseoin-
tegrated trans-femoral amputation prostheses: prospective results
of general and condition-speciﬁc quality of life in 18 patients at
2-year follow-up. Prosthet Orthot Int. 2008;32:29–41.
16. Hagberg K, Ha ¨ggstro ¨m E, Uden M, Bra ˚nemark R. Socket versus
bone-anchored trans-femoral prostheses: hip range of motion and
sitting comfort. Prosthet Orthot Int. 2005;29:153–163.
17. Hall CW. A future prosthetic limb device. J Rehabil Res Dev.
1985;22:99–102.
18. Hall CW, Cox PA, Mallow WA. Skeletal extension development:
criteria for future designs. Bull Prosthet Res. 1976;Spring
(10–25):69–96.
19. Kamme C, Lindberg L. Aerobic and anaerobic bacteria in deep
infections after total hip arthroplasty: differential diagnosis
between infectious and non-infectious loosening. Clin Orthop
Relat Res. 1981;154:201–207.
20. Kapp S. Suspension systems for prostheses. Clin Orthop Relat
Res. 1999;361:55–62.
21. Lyon CC, Kulkarni J, Zimerson E, Van Ross E, Beck MH. Skin
disorders in amputees. J Am Acad Dermatol. 2000;42:501–507.
22. Marks LJ, Michael JW. Science, medicine, and the future: arti-
ﬁcial limbs. BMJ. 2001;323:732–735.
23. Mikkelsen DB, Pedersen C, Højbjerg T, Schønheyder HC. Cul-
ture of multiple peroperative biopsies and diagnosis of infected
knee arthroplasties. APMIS. 2006;114:449–452.
24. Mo ¨ller K, Geijer M, Sollerman C, Lundborg G. Radiographic
evaluation of osseointegration and loosening of titanium implants
in the MCP and PIP joints. J Hand Surg Am. 2004;29:32–38.
25. Mooney V, Schwartz SA, Roth AM, Gorniowsky MJ. Percuta-
neous implant devices. Ann Biomed Eng. 1977;5:34–46.
26. Pezzin LE, Dillingham TR, MacKenzie EJ. Rehabilitation and the
long-term outcomes of persons with trauma-related amputations.
Arch Phys Med Rehabil. 2000;81:292–300.
27. Pezzin LE, Dillingham TR, Mackenzie EJ, Ephraim P, Rossbach
P. Use and satisfaction with prosthetic limb devices and related
services. Arch Phys Med Rehabil. 2004;85:723–729.
28. Robinson KP, Bra ˚nemark R, Ward D. Future developments:
osseointegration in transfemoral amputees. In: Smith DG,
Michael JW, Bowker JH, eds. Atlas of Amputations and Limb
Deﬁciencies: Surgical, Prosthetic and Rehabilitation principles.
Ed 3. Rosemont, IL: American Academy of Orthopaedic Sur-
geons; 2004:673–681.
29. Snik AF, Mylanus EA, Proops DW, Wolfaardt JF, Hodgetts WE,
Somers T, Niparko JK, Wazen JJ, Sterkers O, Cremers CW,
Tjellstro ¨m A. Consensus statements on the BAHA system: where
do we stand at present? Ann Otol Rhinol Laryngol Suppl.
2005;195:2–12.
30. Sullivan J, Uden M, Robinson KP, Sooriakumaran S. Rehabili-
tation of the trans-femoral amputee with an osseointegrated
prosthesis: the United Kingdom experience. Prosthet Orthot Int.
2003;27:114–1120.
31. Tabanella G, Nowzari H, Slots J. Clinical and microbiological
determinants of ailing dental implants. Clin Implant Dent Relat
Res. 2009;11:24–36.
32. von Eiff C, Jansen B, Kohnen W, Becker K. Infections associated
with medical devices: pathogenesis, management and prophy-
laxis. Drugs. 2005;65:179–214. Review.
33. Zimmerli W, Ochsner PE. Management of infection associated
with prosthetic joints. Infection. 2003;31:99–108.
2788 Tillander et al. Clinical Orthopaedics and Related Research
1
123